The aims of this bulletin are to determine the extent to which a sample of people who regularly inject drugs who use opioids in Adelaide, SA (i) are aware of naloxone (2013-2021); (ii) are aware of take-home naloxone programs (2013-2021); (iii) have accessed naloxone (2020-2021); and (iv) have resuscitated peers or have been resuscitated by peers using naloxone (2020-2021) (NDARC)
Bibliography: All Publications
Monitoring drug use in the digital age: studies in web surveys
This collection of papers aims to demonstrate the significant role that web surveys can play in drug data collection (EMCDDA)
Using the Global Drug Survey for harm reduction
This paper looks at the history of the GDS and the range of harm reduction tools that have been created using data from the survey (EMCDDA)
Multiple disadvantage and co-occurring substance use and mental health conditions.
This briefing is informed by conversations with local areas from across the MEAM Approach and Fulfilling Lives networks, providing an in-depth understanding of the difficulties faced by support services – including homelessness, drug and alcohol and mental health services – in meeting the needs of individuals with co-occurring conditions, as well as partnership-working, good practice and changes over time (MEAM)
Prohibited Plants – Environmental Justice in Drug Policy
This report, which draws on TNI’s original research, fieldwork, interviews and a broad literature review, aims to add to this burgeoning debate (TNI)
Cannabis Legalization: 2021–2022 Observations (Policy Brief)
Examines evidence on the impact and implementation of the 2018 Cannabis Act. The report explores progress toward the act’s public health and safety objectives. Policy makers, public health professionals and researchers involved in cannabis regulation will find the report informative (CCSA)
World Drug Report 2022
Consisting of five separate booklets, the World Drug Report 2022 provides an in-depth analysis of global drug markets and examines the nexus between drugs and the environment within the bigger picture of the Sustainable Development Goals, climate change and environmental sustainability (UNODC)
A review of UK public policy; regulatory stewardship of the legal cannabis industry
In February this year following a series of meetings with Ministers, advisers and senior officials in Whitehall the Centre of Medicinal Cannabis and the Association for the Cannabinoid Industry commissioned Oxford University’s Professor Christopher Hodges to oversee a comprehensive review of the UK legal cannabinoid industry with a particular regard to how public policy and regulation can support the sector’s growth and development (Hodges Review, UK)
Giving Drug Policy Decisionmakers the Data They Need
Testimony submitted to the U.S. Senate Caucus on International Narcotics Control on June 22, 2022 (RAND)
Feast or famine
Barriers and solutions to deploying one-year funding for the Universal Grant and Inpatient Detoxification (University of York, The Kings Fund, UK)
European Drug Report 2022: Trends and Developments
European Drug Report 2022: Trends and Developments (EMCDDA)
Challenges in Identifying Novel Psychoactive Substances and a Stronger Path Forward
The importance of non-targeted testing to keep pace with a rapidly evolving synthetic opioid market (National Institute of Justice)
European Drug Report 2022: Trends and Developments
The Trends and Developments report presents the EMCDDA’s latest analysis of the drug situation in Europe. Focusing on illicit drug use, related harms and drug supply, the report contains a comprehensive set of national data across these themes and key harm-reduction interventions (EMCDDA)
Drug supply and use bounce back after COVID-19 disruption
The rapid bounce back of drug supply and use following COVID-19 disruption is among the issues highlighted today by the EU drugs agency (EMCDDA) as it launches its European Drug Report 2022: Trends and Developments
EU Drugs Agency: Council adopts negotiating mandate on strengthening the role of the agency
To step up the fight against illegal drugs, the Council today adopted its negotiating mandate on the proposal on the EU Drugs Agency, meant to turn the existing European Monitoring Centre for Drugs and Drug Addiction into a fully fledged agency and strengthen its role
Illicit Drug Toxicity Deaths in BC January 1, 2012 – April 30, 2022
This report summarizes all unintentional illicit drug toxicity deaths in British Columbia (accidental and undetermined) that occurred between January 1, 2012, and April 30, 2022, inclusive. It includes confirmed and suspected illicit toxicity deaths (BC Coroners Service)
New HRB report examines substance use among young people
The data highlights an increase in substance-related hospitalisations among young people and that treatment for cocaine use among young people increased by 171% between 2011 and 2019. It also shows a clear link between mental ill health and substance use, evident across data on anxiety, self-harm and suicide (HRB Ireland)
Concern about drug addiction has declined in U.S., even in areas where fatal overdoses have risen the most
The share of Americans who see drug addiction as a “major problem” in their community has declined in recent years, even as drug overdose deaths in the United States have risen sharpl (Pew Research Center)
The Drug Use in Higher Education in Ireland (DUHEI) Survey 2021
This analysis provides the first significant body of evidence on drug use among students in Ireland and will help policymakers, professionals, and practitioners when considering responses to the challenge of reducing harms arising from drug use in higher education (DUHEI)
Expanding overdose prevention sites in Vancouver, Canada, has beneficial health impacts
Overdose prevention sites are a type of supervised injection service that are less regimented and have fewer barriers than traditional supervised injection services. The researchers in this study investigated the impact of this implementation in Vancouver on health outcomes (Recovery Research Institute)
- 1
- 2
- 3
- …
- 91
- Next Page »
